Lots of interesting abstracts and cases were submitted for TCTAP 2023. Below are the accepted ones after a thorough review by our official reviewers. Don¡¯t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!
TCTAP A-023
Comparison of Rotational and Orbital Atherectomy: A Systematic Review of Efficacy and Safety in Patients Who Underwent Percutaneous Coronary Intervention
By Saraswati Putri Yogita, I Gede Sumantra, Pintoko Tedjokusumo
Presenter
Saraswati Putri Yogita
Authors
Saraswati Putri Yogita1, I Gede Sumantra2, Pintoko Tedjokusumo2
Affiliation
Puri Raharja General Hospital, Indonesia1, Bandung Adventist Hospital, Indonesia2
View Study Report
TCTAP A-023
Adjunctive Procedures (Thrombectomy, Atherectomy, Special Balloons)
Comparison of Rotational and Orbital Atherectomy: A Systematic Review of Efficacy and Safety in Patients Who Underwent Percutaneous Coronary Intervention
Saraswati Putri Yogita1, I Gede Sumantra2, Pintoko Tedjokusumo2
Puri Raharja General Hospital, Indonesia1, Bandung Adventist Hospital, Indonesia2
Background
To evaluate the clinical outcomes of patients with coronary artery disease (CAD) who underwent rotational atherectomy (RA) and orbital atherectomy (OA).
Methods
Selection process of articles were done systematically according to preferred reporting items for systematic reviews and meta-analyses (PRISMA) and PICO criteria for publication in the last 5 years. Keywords were searched by Boolean operator. STROBE checklist was used to assess the quality of all selected articles.
Results
Five articles of non-randomized observational analysis were selected, which involved 72.982 patients whom underwent RA, while 6.431 others underwent OA which is a new atherectomy method that was approved for use in coronary arteries in 2003. Although some studies still showed varying results due to different data collection tools, overall data showed there was no difference between the two techniques in terms of contrast volume, outcomes of coronary artery dissection, device induced arterial perforation, cardiac tamponade, slow flow/no reflow, periprocedural myocardial infarction (MI), in-hospital mortality, 30-day mortality, 30-day MI, 30-day target vessel revascularization (TVR), and 30-day major adverse cardiovascular events (MACE). Although complication rates may be dependent on the use of some preventive measures proposed by experts including appropriate burr size and rotational speed for RA.
Conclusion
Except for lower fluoroscopy time with OA, there are no significant differences between OA and RA in relation to procedural, periprocedural, and thirty day outcomes among patients with calcified CAD undergoing PCI.